- Report
- December 2024
- 134 Pages
Global
From €3595EUR$3,950USD£3,082GBP
- Report
- August 2024
- 265 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- August 2024
- 150 Pages
Global
From €3413EUR$3,750USD£2,926GBP
- Report
- June 2024
- 200 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- June 2024
- 200 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- June 2024
- 200 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- June 2024
- 200 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- February 2025
- 204 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- February 2025
- 233 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- February 2025
- 216 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- January 2025
- 199 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- January 2025
- 189 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- November 2024
- 159 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- October 2024
- 136 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- October 2024
- 133 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- October 2024
- 137 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- October 2024
- 146 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- October 2024
- 143 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- October 2024
- 145 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- August 2024
- 163 Pages
Global
From €2275EUR$2,500USD£1,951GBP

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy.
The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more